Pfizer's net profit for the second quarter of 2024 was Rs 158.4 crore, showing a 2.3% increase in revenue. This demonstrates the company's efforts to navigate a competitive pharmaceutical landscape.
CAMS, a registrar and transfer agent for mutual funds, reported a profit after tax of Rs 122.5 crore for the quarter ending September 2024, a 45% increase from the same period last year. The company's revenues from operations also rose by 33%, reaching Rs 365.17 crore compared to the previous fiscal year.
A paragraph can also have a simple HTML list: